☆ 4.1 Article

Talimogene laherparepvec pseudolymphomatous reaction mimicking metastatic melanoma

JOURNAL OF CUTANEOUS PATHOLOGY (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Dermatology

Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response

Keith J. Sweeney et al.

Summary: The development of immune checkpoint inhibitor therapy has shifted the paradigm in cancer treatment, with neoadjuvant ICI therapy followed by surgery becoming the standard of care for several advanced-stage cancers. The pathology associated with ICI therapy includes tissue reactions, activation of TLSs, and off-target immune-related adverse events, with clonal expansion of B-cells in TLSs during neoadjuvant therapy being a critical factor in recognizing the response to ICI therapy.

JOURNAL OF CUTANEOUS PATHOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

B cells are associated with survival and immunotherapy response in sarcoma

Florent Petitprez et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink et al.

NATURE (2020)

添加到收藏夹

Letter Dermatology

Rash after a single injection of T-VEC

Daniel Wagenknecht et al.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2019)

添加到收藏夹

Letter Dermatology

Extensive Pigment Incontinence Mimicking Persistent Melanoma After Talimogene Laherparepvec Therapy

Melissa Danesh et al.

JAMA DERMATOLOGY (2019)

添加到收藏夹

Editorial Material Dermatology

The histological spectrum of talimogene laherparepvec (TVEC) injections-Neutrophilic and chronic granulomatous dermatitis

Katrina Lee et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2019)

添加到收藏夹

Article Dermatology

Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastases

Ashlyn S. Everett et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2018)

添加到收藏夹

Review Medical Laboratory Technology

Drug induced pseudolymphoma

Cynthia M. Magro et al.

SEMINARS IN DIAGNOSTIC PATHOLOGY (2018)

添加到收藏夹

Article Dermatology

Panniculitis in a patient with pathologic complete response to talimogene laherparepvec treatment for recurrent, in-transit melanoma

Thomas H. Long et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2018)

添加到收藏夹

Article Oncology

Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Melanoma: A Single-Institution Experience

Matthew C. Perez et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

添加到收藏夹

Letter Oncology

Interstitial granulomatous dermatitis during talimogen laherparepvec treatment

Anna L. Frauchiger et al.

MELANOMA RESEARCH (2017)

添加到收藏夹

Letter Dermatology

Complete Response of Advanced Melanoma Treated With Talimogene Laherparepvec and Subsequent Sweet's-like Infiltrate

Vishwas Parekh et al.

JAMA DERMATOLOGY (2017)

添加到收藏夹

Editorial Material Dermatology

Phenytoin Induced Cutaneous B Cell Pseudolymphoma

Najeeba Riyaz et al.

INDIAN JOURNAL OF DERMATOLOGY (2015)

添加到收藏夹

Review Oncology

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

A. W. Langerak et al.

LEUKEMIA (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.